Inventor · disambiguated record
John William Frank Whitehead
Also filed as: WHITEHEAD JOHN · WHITEHEAD JOHN W F · WHITEHEAD JOHN WILLIAM FRANK
9 granted patents·2 pending applications·158 citations·filing 1991–2019
88Inventor score
Top patents by PatentIndex Score
11 records- 0192US9145408B2Substituted-quinoxaline-type bridged-piperidine compounds as ORL-1 modulatorsPURDUE PHARMA LP·Filed 2013·Granted Sep 29, 2015·13 cites·78 claims
- 0291US6166041A2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthmaEURO CELTIQUE SA·Filed 1997·Granted Dec 26, 2000·85 cites·11 claims
- 0385US6864261B2Therapeutic agents useful for treating painEURO CELTIQUE SA·Filed 2003·Granted Mar 8, 2005·18 cites·77 claims
- 0484US9278967B2Substituted-quinoxaline-type piperidine compounds and the uses thereofPURDUE PHARMA LP·Filed 2014·Granted Mar 8, 2016·6 cites·20 claims
- 0582US8846929B2Substituted-quinoxaline-type piperidine compounds and the uses thereofFUCHINO KOUKI·Filed 2010·Granted Sep 30, 2014·9 cites·111 claims
- 0682US5196534AProcess for the preparation of lactam derivativesGLAXO GROUP LTD·Filed 1991·Granted Mar 23, 1993·24 cites·9 claims
- 0781US9527840B2Substituted-quinoxaline-type piperidine compounds and the uses thereofPURDUE PHARMA LP·Filed 2016·Granted Dec 27, 2016·3 cites·20 claims
- 0873US11111246B2Pharmaceutical salts of substituted-quinoxaline-type bridged-piperidine compoundsPURDUE PHARMA LP·Filed 2019·Granted Sep 7, 2021·0 cites·5 claims
- 0967US10519156B29′-Aza[3,9′-bi(bicyclo[3.3.1]nonan)]-3′-one and preparation thereofPURDUE PHARMA LP·Filed 2018·Granted Dec 31, 2019·0 cites·5 claims
- 1041US2008214827A1Synthesis of Cyanoimino-BenzoimidazolesEURO CELTIQUE SA·Filed 2005·Application pending·0 cites
- 1126US2005272686A1Nucleotide based medicament and method of use for treatment of conditions in humansDENTONE ALFRED J·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John William Frank Whitehead files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →